Ines El Naggar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ines El Naggar has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Kevin Rostásy
Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany
7 shared publications Annikki Bertolini
Department of Pediatric Neurology, Children's Hospital Datteln, Witten/Herdecke University, Datteln, Germany
5 shared publicationsEva-Maria Wendel
Department of Pediatric Neurology, Klinikum Stuttgart/Olgahospital, Stuttgart, Germany
4 shared publicationsAdela Della Marina
Department of Neuropediatrics, Developmental Neurology and Social Pediatrics, Centre for Neuromuscular Disorders in Children, University Hospital Essen University of Duisburg-Essen, Essen Germany
3 shared publicationsCharlotte Thiels
Department of Neuropediatrics and Socialpediatrics, University Hospital of Ruhr University Bochum, Bochum, Germany
3 shared publicationsMichael Karenfort
Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich Heine University Duesseldorf, Germany
3 shared publications
Latest Publications
- 25 September 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 59, 18-22
Evolution of neuroimaging features in children with acute flaccid myelitis compared to other forms of childhood myelitis
- 25 September 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 59, 18-22
Evolution of neuroimaging features in children with acute flaccid myelitis compared to other forms of childhood myelitis
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (3)
Prevalence of the Central Vein Sign on Susceptibility-Weighted Imaging in People With Pediatric-Onset Multiple Sclerosis
- 1 September 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (3)
Prevalence of the Central Vein Sign on Susceptibility-Weighted Imaging in People With Pediatric-Onset Multiple Sclerosis
- 24 January 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 54, 113-120
Characterization of children with early onset pediatric multiple sclerosis
- 24 January 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 54, 113-120
Characterization of children with early onset pediatric multiple sclerosis
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (1) , e200337
Distinguishing Transient From Persistent Brain Structural Changes in Pediatric Patients With Acute Disseminated Encephalomyelitis
Pediatric patients with acute disseminated encephalomyelitis (ADEM) are at risk of impaired brain growth, with long-term neuropsychiatric consequences. We previously reported transient expansions of cerebral ventricle volume (VV) in experimental autoimmune encephalomyelitis, which subsequently normalized. In this study, we investigated changes in VV in ADEM in relation to other brain structures and clinical outcomes. We investigated brain MRI scans acquired in routine clinical practice from a multicenter cohort of 61 pediatric patients with ADEM, of whom 39 were myelin oligodendrocyte glycoprotein (MOG) antibody-positive. Patients were compared with 1,219 pediatric healthy controls (HCs). Volumes of multiple brain structures were computed using a contrast-agnostic machine learning-based tool and analyzed with mixed-effect models regarding other clinical parameters. Patients with ADEM had larger VV than HCs at initial clinical presentation, before immune therapy. Most of the patients showed further VV increases within 2 months after disease onset. Patients had smaller brain volumes than HCs, with specific reductions in deep gray matter structures. These changes were more pronounced in MOG antibody-negative patients.Of the patients with more than 2 MRI scans, 12 of 22 resolved their VV expansion back to within 15% of baseline values while 10 of 22 had persistently increased VV at the last available MRI within 1 year from onset. Patients with persistent VV expansion had greater reductions in volumes of other brain structures at the last MRI than patients whose VV resolved and were more likely to have residual neurologic signs. The VV resolving and nonresolving patients did not differ regarding age, sex, elevated CSF cell counts at baseline, or occurrence of relapses. However, patients with a larger magnitude of VV expansion-≥90% of baseline volume-were more likely to be in the nonresolving group. We could distinguish between 2 outcomes of VV changes in ADEM: one in which the VV expanded but ultimately returned to normal and one in which the expansions continued after disease onset and treatment but failed to resolve. The latter was associated with reduced brain volume, particularly in deep gray matter structures. This highlights the necessity for patients with ADEM to undergo regular MRI scans to assess whether developing VV expansions indicate a greater risk of permanent brain atrophy.
- 1 January 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (1) , e200337
Open AccessDistinguishing Transient From Persistent Brain Structural Changes in Pediatric Patients With Acute Disseminated Encephalomyelitis
Pediatric patients with acute disseminated encephalomyelitis (ADEM) are at risk of impaired brain growth, with long-term neuropsychiatric consequences. We previously reported transient expansions of cerebral ventricle volume (VV) in experimental autoimmune encephalomyelitis, which subsequently normalized. In this study, we investigated changes in VV in ADEM in relation to other brain structures and clinical outcomes. We investigated brain MRI scans acquired in routine clinical practice from a multicenter cohort of 61 pediatric patients with ADEM, of whom 39 were myelin oligodendrocyte glycoprotein (MOG) antibody-positive. Patients were compared with 1,219 pediatric healthy controls (HCs). Volumes of multiple brain structures were computed using a contrast-agnostic machine learning-based tool and analyzed with mixed-effect models regarding other clinical parameters. Patients with ADEM had larger VV than HCs at initial clinical presentation, before immune therapy. Most of the patients showed further VV increases within 2 months after disease onset. Patients had smaller brain volumes than HCs, with specific reductions in deep gray matter structures. These changes were more pronounced in MOG antibody-negative patients.Of the patients with more than 2 MRI scans, 12 of 22 resolved their VV expansion back to within 15% of baseline values while 10 of 22 had persistently increased VV at the last available MRI within 1 year from onset. Patients with persistent VV expansion had greater reductions in volumes of other brain structures at the last MRI than patients whose VV resolved and were more likely to have residual neurologic signs. The VV resolving and nonresolving patients did not differ regarding age, sex, elevated CSF cell counts at baseline, or occurrence of relapses. However, patients with a larger magnitude of VV expansion-≥90% of baseline volume-were more likely to be in the nonresolving group. We could distinguish between 2 outcomes of VV changes in ADEM: one in which the VV expanded but ultimately returned to normal and one in which the expansions continued after disease onset and treatment but failed to resolve. The latter was associated with reduced brain volume, particularly in deep gray matter structures. This highlights the necessity for patients with ADEM to undergo regular MRI scans to assess whether developing VV expansions indicate a greater risk of permanent brain atrophy.
- 11 October 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 92, 105926
Long-term follow-up MR imaging in children with transverse myelitis
- 11 October 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 92, 105926
Long-term follow-up MR imaging in children with transverse myelitis
- 17 August 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 53, 1-7
CSF-profile and hypocretin levels in children with narcolepsy type 1 and 2
- 17 August 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 53, 1-7
CSF-profile and hypocretin levels in children with narcolepsy type 1 and 2
- 20 September 2022
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 41, 27-35
Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially
- 20 September 2022
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 41, 27-35
Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially
- 22 July 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 67, 104068
MR imaging in children with transverse myelitis and acquired demyelinating syndromes
- 22 July 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 67, 104068
MR imaging in children with transverse myelitis and acquired demyelinating syndromes